No Detail Found!

Dexmedetomidine versus Ketofol for Moderate Sedation in Endoscopic Retrograde Cholangiopancreatography

Author(s)
Nida Aqeel Department of Anaesthesia, SICU and Pain Management, Sindh Institute of Urology and Transplantation,Karachi,Pakistan
Muhammad Qamar Abbas Department of Anaesthesia, SICU and Pain Management, Sindh Institute of Urology and Transplantation,Karachi,Pakistan
Syed Muhammad Abbas Department of Anaesthesia, SICU and Pain Management, Sindh Institute of Urology and Transplantation,Karachi,Pakistan
Muhammad Faisal Farooq Department of Anaesthesia, SICU and Pain Management, Sindh Institute of Urology and Transplantation,Karachi,Pakistan
Muhammad Siddique Department of Anaesthesia, SICU and Pain Management, Sindh Institute of Urology and Transplantation,Karachi,Pakistan
Shakeel Malik Department of Anaesthesia, SICU and Pain Management, Sindh Institute of Urology and Transplantation,Karachi,Pakistan
Abstract
Objective: To compare the e cacy of dexmedetomidineversus ketofol for moderate sedation in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP). Study Design: Randomised controlled trial. Place and Duration of the Study: Department of Anaesthesia, SICU and Pain Management, Sindh Institute of Urology and Transplantation, Karachi, Paksitan, from December 2021 to June 2022. Methodology: Sixty-two patients aged 20-60 years of any gender scheduled for elective ERCP were included. Patients were randomly divided into Dexmedetomidine group (2ml ampule of 100ug/ml diluted in 18ml of normal saline) and Ketofol group (2ml ketamine and 10ml of propofol 1% diluted in 8ml of normal saline) for sedation. The mean di erence in time to achieve Ramsay Sedation Scale (RSS) score of 4 and Modi ed Aldrete s Score (MAS) of 9 were noted as outcomes in each group. In addition, complications during the procedure and recovery were also noted. Results: The mean age was 39.15 ± 9.82 years. There were 33 (53.2%) males and 29 (46.8%) females. The mean time to achieve RSS 4 was signi cantly lower in patients who were treated with Dexmedetomidine as compared to Ketofol, i.e., 11.84 ± 1.77 minutes vs. 13.10 ± 1.64 minutes respectively (p-value 0.005, 95% CI -2.12 to -0.39). Similarly, the mean time to achieve MAS score 9 was signi cantly lower in patients who were treated with Dexmedetomidine as compared to Ketofol, i.e., 11.19 ± 1.72 minutes vs. 12.23 ± 1.84 minutes, respectively (p-value 0.026, 95% CI -1.94 to -0.13). Conclusion: Dexmedetomidine proved to be more e ective than Ketofol for sedation in ERCP, achieving faster sedation and quicker recovery.
Publication Details
Page(s) 1019-1023
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 34, Issue: 9, Year: 2024

Request the full text from PASTIC

Keywords
Dexmedetomidine, Sedation, Endoscopic retrograde cholangiopancreatography, ketofol
0

Citations

0

Downloads

99

Views